Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01349
http://purl.obolibrary.org/obo/dinto_DB01349
|
|---|---|
| Preferred Name | tasosartan |
| Synonyms |
C23H21N7O
2,4-dimethyl-8-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | tasosartan
|
|---|---|
| label | tasosartan
|
| ATCCode | C09CA05
|
| Definition | Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertension
|
| has pharmacological target | |
| type | |
| InChIKey | InChIKey=ADXGNEYLLLSOAR-UHFFFAOYSA-N
|
| is metabolised by | |
| blocks | |
| Synonym | C23H21N7O
2,4-dimethyl-8-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one
|
| xref |
BindingDB:50040439
PubChem Substance:46504809
Wikipedia:http://en.wikipedia.org/wiki/Tasosartan
ChemSpider:54890
PharmGKB:PA164769057
PubChem Compound:60919
See more
See less
|
| CASRN | 145733-36-4
|
| prefixIRI | obo2:dinto_DB01349
|
| SMILES | CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1
|
| may interact with | |
| InChI | InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |